INTRODUCTION
Toll like receptors (TLR) and retinoic acid inducible gene I (RIG-I) like helicases (RLH) are two major families of pattern recognition receptors (PRRs) that recognize cytosolic viral RNA pathogen associated molecular patterns (PAMPs) in vertebrates (11, 22) . For example, TLR-3 and -7 are endosome associated cellular PRRs recognising viral PAMPs released from the uncoating process. In contrast, RIG-I like helicases sense viral derived RNA molecules in other regions of the cytoplasm. Upon activation, TLRs and RLHs trigger production of type I interferons (IFNs), leading to an enhanced antiviral state of the host cells.
The RLH family contains three members, RIG-I, melanoma differentiation associated gene 5 (MDA5) and laboratory of genetics and physiology 2 (LGP2), all of which share homologous core structural domains including a DExD/H box helicase domain, helicase C terminal domain and a C terminal domain (CTD) of RIG-I (11, 22) . The central helicase domain contains six conserved DExD/H helicase motifs and is involved in translocation, ATP hydrolysis and RNA binding (36) . The CTD, also referred to as the repressor domain or carboxy-terminal regulatory domain (RD), has proven to contain multiple diverse functions such as signaling repression, RNA recognition and protein dimerization (5, 25) . RIG-I and MDA5 have additional caspase activating and recruiting domains (CARDs) at the N terminus that are well conserved in proteins involved in immune signaling, cell differentiation and apoptosis (1, 18) . Activated RIG-I and MDA5 act on the mitochondria via interaction of CARD domains between RIG-I/MDA5 and mitochondria antiviral signaling protein (MAVS), a mitochondrial receptor which also contains a CARD, facilitating phosphorylation of interferon regulatory factor (IRF) -3 and -7 which are key transcription factors involved in triggering IFN production (12, 26, 35) .
Whilst it is certain that RIG-I and MDA5 serve as PRRs for viral PAMPs, the role of LGP2 in mediating an antiviral response is contradictory. Since LGP2 lacks CARD domains at the N terminal region, it is believed that it is unable to interact with MAVS and hence may serve as a negative mediator for RIG-I/MDA5 activated antiviral signaling (24, 31, 35) . Over-expression of LGP2 was shown to result in decreased IFN production in cells following transfection with polyI:C or viral infection.
Furthermore, LGP2 deficient mice exhibited enhanced resistance to viral infection and embryonic fibroblasts isolated from these mice displayed enhanced IFN expression in response to synthetic double stranded RNA. However, positive regulatory roles of LGP2 in RIG-I/MDA5 activated antiviral signaling have also been reported in LGP2 deficient mice which lost the ability to synthesise type I IFNs and were unable to mount efficient antiviral responses against infection with encephalomyocarditis virus (32) . A more recent study has provided further evidence that the ATPase domain of LGP2 is required for the LGP2 positive regulatory role in mediating RIG-I/MDA5 dependent antiviral responses (26) .
In teleost fish, orthologs of human TLRs which recognize viruses have been reported in zebrafish (4, 16, 21) , rainbow trout (19, 23) , Atlantic salmon (28) , grass carp (29) and gilthead seabream (6) . Concerning RLRs, recent studies from our group and others have demonstrated that fish also possess RLR molecules, among which RIG-I and MAVS have been shown to activate the interferon response via a mitochondria associated signaling pathway (2, 14, 36) . Over-expression of fish RIG-I and MAVS in cultured cells up-regulates expression of IFN and IFN stimulated genes and enhances resistance against not only RNA viruses but also DNA viruses (2, 14) .
As in mammals, the CARD domains at the N-terminal region in both RIG-I and MAVS and the CTD in RIG-I are essential for their antiviral activities. In the present study, we identified two other members of the RLR family, MDA5 and LGP2, known in mammals to be involved in mediating antiviral immunity, from rainbow trout (Oncorhynchus mykiss), and demonstrated that they were induced at the transcriptional level by viral infection, exogenous cytosolic double stranded RNA (dsRNA) and stimulation with type I IFN. Induction of MDA5 and LGP2 expression was confirmed at the protein level by Western blot analysis using polyclonal antibodies produced against MDA5 and LGP2 peptides. To further clarify the role of trout MDA5 and LGP2, stable trout cell lines overexpressing these RLR molecules were generated and shown to exhibit enhanced resistance to infection against a RNA virus (viral hemorrhagic septicemia virus). Strikingly, we found a novel LGP2 variant, containing a shortened CTD with a deletion of 54 amino acid residues at the Cterminus, was unable to trigger antiviral responses and downregulated LGP2 induced Mx gene expression. Furthermore, overexpression of MDA5 had no effect on LGP2 in transfected cells, and vice versa. Taken together, our data indicate that MDA5 and
LGP2 act as independent positive regulators of the IFN response in fish cells whilst the LGP2 variant antagonises LGP2 function.
MATERIALS AND METHODS

Cells and viruses.
The RTG-2 cells were maintained in L-15 medium supplemented with 10% foetal bovine serum (FBS) (Sigma), 100 U/ml penicillin (P) and 100 µg/ml streptomycin (S) at 20 (isolated from a field sample, Inch Kenneth, Scotland; unpublished) was propagated in CHSE-214 cells for 7 days as described previously (15) . Viral hemorrhagic septicaemia virus (VHSV, isolate DK-F1) was propagated at 15°C on 90% confluent monolayers of BF-2 cells (bluegill fry, ATCC No. CCL-91) and cultured in EMEM supplemented with 5% FBS. Once a full cytopathic effect (CPE) was observed, the virus (TCID 50 ) was titrated using BF-2 cells by end point dilution and stored at -80°C in aliquot.
Cloning and sequencing of trout MDA5 and LGP2. To search for salmonid MDA5 and LGP2 homologues, expressed sequence tag (EST) sequences in the NCBI database were searched using fish MDA5 and LGP2 protein sequences (37) as bait sequences for BLASTN analysis. Several candidate ESTs were found with high sequence homology to known MDA5s, among which EST sequences GE782837 (Salmo salar) and GE823089 (Oncorhynchus mykiss) aligned well with the N and C terminal sequences of MDA5 respectively. Forward (MDA5-F1) and reverse (MDA5-R1 and MDA5-R2) primers were designed in the 5' and 3' end untranslated region (UTR), to amplify the full length coding sequence of trout MDA5 by semi-nested RT-PCR. For LGP2, the full length sequence of S. salar was compiled using the CAP3 sequence assembly program (http://pbil.univ-lyon1.fr/cap3.php) with the following ESTs: GE781785, DW582483, DW538655, CX355611, DN165806, DW567942 and CK880416, and primers LGP2-F1 and LGP2-R1 located in the 5' and 3' end UTR were used for RT-PCR amplification of the full length coding sequence of trout LGP2. Hot start PCR was performed for amplification of both molecules under To generate expression vectors of MDA5-GFP and LGP2-GFP fusion proteins for cellular localization studies, the full length coding sequences of MDA5, LGP2a and
LGP2b were amplified with primer pairs ptGFPMDAF/GFPMDAR1, ptGFPLGP2F/GFPLGP2aR and ptGFPLGP2F/GFPLGP2bR (Table 1) Recombinant proteins of trout MDA5 and LGP2 were produced to verify the polyclonal antibodies generated against the synthetic peptides. For this, the full length cDNA fragments of MDA5, LGP2a and LGP2b were amplified using the primers listed in Table 1 , inserted into the pQE30 vector (Qiagen) and expressed in E.coli M15 cells (Qiagen). The recombinant MDA5 and LGP2 proteins were produced as previously described and purified under denaturing conditions (38) . The recombinant proteins were separated on a 4-12% pre-cast SDS-PAGE gel (Invitrogen) and transferred onto a polyvinylidene difluoride membrane. Western blotting was performed using a WesternBreeze® Chemiluminescent Western Blot
Immunodetection Kit (Invitrogen). The primary antibodies were diluted 400-fold.
To examine the expression of MDA5 and LGP2 at the protein level in RTG-2 cells, the cells were passaged into 25-cm 2 flasks and cultured at 20°C until they reached 80% confluence (2 days), the culture media were replaced by fresh media and an equal volume of PBS or polyI:C (50 or 100 µg/ml) was added. After 24 h, when the cells were harvested and resuspended in 1×SDS-PAGE sample buffer. Cell lysates were boiled at 95°C for 5 min, centrifuged at 13,000 × g for 1 min and loaded immediately onto the SDS-PAGE gels. After gel electrophoresis, a Western blot was performed as described previously using polyclonal antibodies against MDA5 and
LGP2. Actin protein was detected with mouse monoclonal anti-actin ( 
Interaction of MDA5 and LGP2 in RTG-2 cells
To study whether overexpression of MDA5 affects LGP2 expression, 5 x 10 6 RTG-2 cells were transfected with 2 µg of p3xFLAG-CMV-14 vector (Sigma), pMDA5-Flag, ptGFP1 or ptGFP1-LGP2a plasmid as described above. The cells were immediately washed with HBSS buffer, cultured in 10% FBS containing L-15 medium at 20°C for 48 h, and collected for protein extraction using cell extraction buffer (Invitrogen). Western blotting was performed to determine trout MDA5 and
LGP2 proteins as described above.
Binding affinity of MDA5 and LGP2 with polyI:C Poly(C)-conjugated agarose beads (Sigma) and poly(I) were resuspended in buffer containing 50 mM Tris (pH 7.0) and 150 mM NaCl to a final concentration of 2 mg/ml and mixed at a ratio of 1:2 (v/v). The mixture was incubated at 4 o C overnight, centrifuged at 1,000 × g for 1 min and washed once. The beads was resuspended in the same buffer as a 50% slurry and stored at 4°C for use.
Poly(I:C) pull-down assays were performed as described by Sumpter et al. (31) .
The poly(I:C)-coated beads were equilibrated in binding buffer containing 50 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA and 1% NP-40 and resuspended as a 10% slurry. The beads were then incubated with the purified recombinant MDA5,
LGP2a or
LGP2b at 4°C for 1 h, centrifuged at 1,000 × g, rinsed three times with binding buffer, resuspended in three volumes of 1× SDS-PAGE sample buffer, and boiled for 3 min before being loaded onto a SDS-PAGE gel for Western blotting. For competition experiments, the polyI:C coated beads were incubated with recombinant proteins and 50 µg/ml of polyI:C.
Statistical analysis. The relative expression of target genes was normalized to the expression of elongation factor (EF) -1α and expressed as arbitrary units or fold change relative to the corresponding control group. The mean of at least three independent experiments was used for statistical analysis using the paired student t test. P<0.05 was considered to be significantly different. LGP2a (Fig. S1B) . TMpred analysis showed that the LGP2a and LGP2b proteins contained a transmembrane helix at aa 549-568. Pfam HMM analysis predicted a typical type III restriction enzyme res subunit domain (aa 3-176) at the N terminus, which is highly homologous to the DExD/H helicase domain of MDA5. The helicase C terminal domain (aa 396-477) and the RIG-I CTD domain (aa 552-672) were also detected both in LGP2a and LGP2b (Fig. S1B) . The Type III restriction enzyme subunit, conserved C-terminal helicase domain and the CTD domain of trout
RESULTS
Sequence
LGP2a/LGP2b has a similarity of 73.0%, 74. The expression level of trout MDA5, LGP2a and LGP2b in RTG-2 cells was higher than that in RTS-11 cells. In RTG-2 cells, MDA5 transcript level was the lowest among the 3 genes, however it was higher relative to LGP2a/LGP2b expression in the RTS-11 cells (Fig. 1A) .
To study the effect of the double stranded synthetic RNA, polyI:C, a known activator of MDA5 and LGP2 in mammals, the trout RTG-2 and RTS-11 cells were stimulated by addition of polyI:C (50 µg/ml) into the culture media for 4 h and 24 h. LGP2a and LGP2b were all induced, with an approx. 9-, 200-and 18-fold increase of expression level respectively (Fig. 1C) .
In mammals, activation of RIG-I/MDA5 by viral RNA PAMPs induces IFN expression and these surveillance mechanisms are enhanced by the synthesized IFNs via a positive feedback. In this study, the RTG-2 cells stimulated with 20 ng/ml rIFN2 for 4 h and 24 h exhibited increased expression for MDA5, LGP2a and LGP2b (Fig.   1D ). Notably, a 36-fold increase in MDA5 transcript level was detected at 4 h whilst the increase reduced to 5-fold at 24 h.
To confirm induction of MDA5 and LGP2 detected by real time PCR, polyclonal antibodies were raised against synthetic MDA5 and LGP2 peptides for Western blot analysis. The polyclonal antibodies reacted well with the recombinant proteins produced in bacteria ( Fig. 2A) . These antibodies were used to analyse MDA5 and
LGP2 protein expression in RTG-2 cells after polyI:C stimulation by Western blotting.
In control cells, a low level of constitutive expression was detected for MDA5 and the two isoforms of LGP2. Induction of all three proteins after 24 h stimulation with either 50 or 100 µg/ml polyI:C was apparent (Fig. 2B) . These data confirmed the transcriptional results obtained by real time PCR.
Kinetics of trout MDA5 and LGP2 expression in response to viral hemorrhagic septicemia virus (VHSV) and salmon alpha virus (SAV) infection.
Expression of MDA5 and LGP2 was studied in trout after infection with VHSV, a virus with a single stranded negative RNA genome (Fig. 3A) . At day one post-infection, increased transcript level of MDA5, LGP2a and LGP2b was detected.
MDA5 expression appeared to stay at a constant level during the 12 day sampling period whilst induction of LGP2a peaked at day 3. Compared with MDA5 and LGP2a, a much bigger increase of gene expression was observed for IFN2.
SAV is a single stranded positive RNA virus which infects salmonid species.
Recent studies have shown that SAV infection led to elevation of IFN and Mx expression in TO cells (3, 8) . In the present work, the expression of MDA5 and LGP2 was analysed to establish whether these cytosolic PRRs were also involved in antiviral responses against infection of RNA viruses with a positive genome. During the 8 day infection period, expression of MDA5, LGP2a and LGP2b were induced from day 2 and peaked at day 6. Induction patterns were similar for all 3 molecules, but the magnitude of trout LGP2a induction was higher than that of MDA5 or LGP2b (Fig. 3B) .
Localization of trout MDA5 and LGP2 within cells. To determine their localization within cells, the open reading frames (ORFs) of trout MDA5, LGP2a and
LGP2b were inserted into the pTurboGFP-N expression vector, to facilitate over-production of fusion proteins in transfected cells. The RTG-2 cells transfected with plasmids pTurbo-GFP (vector), pTurbo-MDA5-GFP, pTurbo-LGP2a-GFP, or pTurbo-LGP2b-GFP were tested by Western blot analysed for confirmation of expression of fusion proteins and examined under a fluorescent microscope 24 h after transfection. The presence of LGP2a-GFP and LGP2b-GFP proteins were confirmed using a polyclonal antibody against the GFP protein (Fig. 4A) . A global cytosolic distribution was seen for all three GFP fusion proteins (Fig. 4B) . However, marked intensified green spots were apparent for the two LGP2 isoforms, most of which were located in the region surrounding the nucleus, possibly the nuclear envelope and LGP2b, respectively (Fig. 5A) . In each case, the expression of Mx was significantly increased in MDA5 and LGP2a transfected cells (P<0.5) but not in
LGP2 transfected cells (Fig. 5B ). These cells were also examined for their resistance against VHSV infection. The cells transfected with MDA5 and LGP2a were more resistant to VHSV infection than the control cells tranfected with empty vector plasmid (Fig. 6 ). Over-expression of LGP2b had little impact on the antiviral state of the cells.
Inhibitory activity of LGP2b on
LGP2a activated antiviral response. To further investigate whether LGP2b has any effect on the LGP2a elicited antiviral responses, RTG-2 cells were co-transfected with 5 µg polyI:C and ptGFP1 (2 µg), ptGFP1-LGP2a (2 µg), ptGFP1-LGP2b (2 µg), or ptGFP1-LGP2a (2 µg) plus ptGFP1-LGP2b (2 µg), and cultured for 6 h. The cells co-transfected with LGP2a and
LGP2b exhibited decreased Mx expression compared with cells transfected with
LGP2a alone (Fig. 7 ) (P<0.05), demonstrating that LGP2b suppresses the LGP2a induced antiviral reponses.
Interaction of MDA5 and LGP2 in RTG-2 cells
It has been recently demonstrated that LGP2 is involved in the primary recognition of encephalomyocarditis virus upstream of MDA5 during signaling (26) . To study whether LGP2 regulates MDA5 expression, MDA5 was over-expressed in transfected RTG-2 cells where LGP2 expression was analysed by Western blotting using polyclonal antibodies. The MDA5 protein was apparently not affected by LGP2 (Fig.   8) . Similarly, overexpression of MDA5 did not result in any change of LGP2 at the protein level. These data suggest that MDA5 and LGP2 may serve as parallel positive regulators to activate IFN system.
Binding affinity of MDA5 and LGP2 with polyI:C
To determine whether trout MDA5, LGP2a and LGP2b bind to synthetic polyI:C, polyI:C pulldown assay was performed using polyI:C conjugated agarose. All three proteins bound to polyI:C as shown in Fig. 9 and the binding was inhibited by co-incubation with soluble polyI:C. In the case of MDA5 and LGP2b, inhibition by polyI:C was incomplete as a small amount of proteins were still able to bind to the polyI:C agarose. No proteins were detected from poly© conjugated agarose for all three proteins. LGP2 variant with a deletion of 54 aa residues at the C terminus, likely associated with the nuclear envelope/endoplasmic reticulum, possibly acts as a negative regulator of the LGP2 activated antiviral response by competing for viral PAMPs. The organization of the structural domains in the trout LGP2 is conserved. Like
DISCUSSION
LGP2 molecules in mammals, trout LGP2 has a DExD/H box helicase, a helicase conserved C-terminal domain and a CTD but lacks N terminal CARD domains. All key motifs including the ATP binding motif, the ATPase motif and RNA unwinding motif, are identical, except for the RNA binding loop which is 2 aa shorter in trout
LGP2. This RNA binding loop was crucial for the binding specificity and affinity with various types of RNA molecules (31) . Interestingly, a splicing variant (namely
LGP2b), possibly originated from incomplete splicing of an intron in the RNA transcript, was sequenced. The LGP2 mRNA contained an early translation stop and thus translated into a protein with an incomplete CTD which has a deletion of 54 aa residues at the C terminus. Alignment analysis of the incomplete trout LGP2b CTD with the human LGP2 CTD showed that the trout LGP2b was devoid of the β6-β8
sheets and the α3 helix (31). One interesting finding in the present study is that LGP2 appears to act as an activator of the antiviral system in fish, which is in contrast to some reports in mammals where LGP2 was shown to suppress RIG-I and MDA5 activated IFN responses (13, 24) .
LGP2 lacks CARD domains at the N terminal region but possesses other domains including a DExD/H helicase domain, a helicase C terminal domain and a C terminal domain of RIG-I, and is believed to sequester the viral RNA PAMPs from the RIG-I and MDA5 molecules, hence acting as a negative regulator to control excessive production of IFNs (which is detrimental to the host immune system) and keeping the IFN level in check when viral infection diminishes.
LGP2 knockout mice showed a higher level of IFNs than the wild type animals and were more resistant to vesicular stomatitis virus infection (32) . However these LGP deficient mice exhibited impaired type I IFN production in response to infection with a different virus, encephalomyocarditis virus, and thus were more susceptible to this virus (32). Satoh et al. (26) LGP2a and LGP2b pulled down from polyI:C coupled agarose; lanes 2 and 4:
LGP2a and LGP2b pulled down from co-incubation with soluble polyI:C; lanes 5 and 6, LGP2a and LGP2b pulled down from polyC coupled agarose. Table 1 Primer sequences used in this study
Primer name Sequences Application MDA5-F1 TGAAAGTGCTTGCATTGACGGGA
MDA5-R1 CACACTGCATCAATGACGGCTTTC
MDA5-R2 CTACCACAGATACACGGAGCTG
LGP2-F1 GTGGACCAATAGACCGGTAGGA
LGP2-R1 CATAGGACTATGACACACTTCAGGA LGP2aF ACACCTGCTCTTTCCGTCAC
LGP2aR GTTGGCTGGATGTCCTTTGG
LGP2bF GTGGCAGGCAATGGGGAATG
LGP2bR CCTCCAGTGTAATAGCGTATCAATCC EF-1αF CAAGGATATCCGTCGTGGCA EF-1αR ACAGCGAAACGACCAAGAGG
MDA5Rexo GAGCCGCGGTACCTTACATTG
LGP2Rexo GAGCCGCGGTACCTCAATCCAAC
LGP2bFexo AGCACCTTTCGCCAGAGTAGCC
LGP2aFall TGGCAGGCAATGGGGAATG
LGP2aRall TAAACTCCTCCACTGTAAACTCAAC Real time PCR 
MDA5
LGP2a
LGP2b LGP2a-GFP
LGP2b-GFP 
